CLINICAL_TRIALS
trial_result
· 2016-03-23
Clinical Trial Update: Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder [Phase 2]
Summary
Phase 2 trial evaluating riluzole augmentation in treatment-refractory obsessive-compulsive disorder has completed with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Obsessive-compulsive Disorder, Ocd | Phase 2 | Status: COMPLETED | Results posted: 2016-03-23